Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)

Objective: The primary objective of this work was to confirm the occurrence of rare BCR ABL fusion variant involving the a3 region of the ABL gene in a patient positive for t(9;22) translocation but negative for common major and minor breakpoint cluster regions and the challenges and threats that it...

Full description

Saved in:
Bibliographic Details
Main Authors: Salil Vaniawala, Arpan Acharya, Harsh Parekh, Pratap N. Mukhopadhyaya
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.3233/ACP-130083
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568470208774144
author Salil Vaniawala
Arpan Acharya
Harsh Parekh
Pratap N. Mukhopadhyaya
author_facet Salil Vaniawala
Arpan Acharya
Harsh Parekh
Pratap N. Mukhopadhyaya
author_sort Salil Vaniawala
collection DOAJ
description Objective: The primary objective of this work was to confirm the occurrence of rare BCR ABL fusion variant involving the a3 region of the ABL gene in a patient positive for t(9;22) translocation but negative for common major and minor breakpoint cluster regions and the challenges and threats that it poses in a routine laboratory setting which use commercial kits for monitoring the minimal residual disease.
format Article
id doaj-art-f9475748fe564f78a481cac5f2e909f9
institution Kabale University
issn 2210-7177
2210-7185
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-f9475748fe564f78a481cac5f2e909f92025-02-03T00:59:00ZengWileyAnalytical Cellular Pathology2210-71772210-71852013-01-01363-4859210.3233/ACP-130083Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)Salil Vaniawala0Arpan Acharya1Harsh Parekh2Pratap N. Mukhopadhyaya3SN Genelab, Surat, Gujarat, IndiaDr. D. Y. Patil Biotechnology & Bioinformatics Institute, Tathawade, Pune, IndiaInterdisciplinary Science, Technology and Research Academy, AISC, New Modhikana, Katad Khana, Pune, IndiaInterdisciplinary Science, Technology and Research Academy, AISC, New Modhikana, Katad Khana, Pune, IndiaObjective: The primary objective of this work was to confirm the occurrence of rare BCR ABL fusion variant involving the a3 region of the ABL gene in a patient positive for t(9;22) translocation but negative for common major and minor breakpoint cluster regions and the challenges and threats that it poses in a routine laboratory setting which use commercial kits for monitoring the minimal residual disease.http://dx.doi.org/10.3233/ACP-130083
spellingShingle Salil Vaniawala
Arpan Acharya
Harsh Parekh
Pratap N. Mukhopadhyaya
Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)
Analytical Cellular Pathology
title Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)
title_full Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)
title_fullStr Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)
title_full_unstemmed Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)
title_short Rare e14a3 (b3a3) BCR-ABL Fusion in Chronic Myeloid Leukemia in India: The Threats and Challenges in Monitoring Minimal Residual Disease (MRD)
title_sort rare e14a3 b3a3 bcr abl fusion in chronic myeloid leukemia in india the threats and challenges in monitoring minimal residual disease mrd
url http://dx.doi.org/10.3233/ACP-130083
work_keys_str_mv AT salilvaniawala raree14a3b3a3bcrablfusioninchronicmyeloidleukemiainindiathethreatsandchallengesinmonitoringminimalresidualdiseasemrd
AT arpanacharya raree14a3b3a3bcrablfusioninchronicmyeloidleukemiainindiathethreatsandchallengesinmonitoringminimalresidualdiseasemrd
AT harshparekh raree14a3b3a3bcrablfusioninchronicmyeloidleukemiainindiathethreatsandchallengesinmonitoringminimalresidualdiseasemrd
AT pratapnmukhopadhyaya raree14a3b3a3bcrablfusioninchronicmyeloidleukemiainindiathethreatsandchallengesinmonitoringminimalresidualdiseasemrd